PDCD1 and neoplasm: reported that corticosteroid treatment resulted in profound reduction in CD4+ and CD8+ T cells and a decrease in anti-tumor efficacy of anti-PD-1 in mice bearing subcutaneous MC38 colon adenocarcinoma, compared to sham-treated controls (206).